Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0024897,
umls-concept:C0031809,
umls-concept:C0037993,
umls-concept:C0040113,
umls-concept:C0079720,
umls-concept:C0229664,
umls-concept:C0301872,
umls-concept:C0439849,
umls-concept:C0445223,
umls-concept:C0597879,
umls-concept:C1304884,
umls-concept:C1511649,
umls-concept:C1552599,
umls-concept:C1704787,
umls-concept:C2348628
|
pubmed:issue |
2
|
pubmed:dateCreated |
1987-1-13
|
pubmed:abstractText |
To assess the significance of humoral immune mechanisms in host reactivity against the P815X2 mastocytoma grown in syngeneic DBA/2 mice, an approach was made to correlate immunomorphology of the thymus and spleen with the functional assays measuring cytotoxic (51Cr-release assay) and tumor cell membrane-bound antibodies (IF test) as well as phenotyping (with monoclonal antibodies Anti-Thy1.2, Anti-Lyt1, Anti-Lyt2, and Anti-I-Ad) the lymphocyte subsets in peripheral blood. The volume fractions (Vv) of the cortex (C), and medulla (M) of the thymus, as well as central (C-PALS) and peripheral periarteriolar lymphoid sheath (P-PALS) in the spleen were determined morphometrically. There was a steady increase of the C/M ratio from the control levels until day 8, not accompanied by any major fluctuations in the percentages of Thy1.2+ or I-Ad+ cells in C and M. In M, two significant peaks were found in Lyt1+/Lyt2+ cell ratio. In the spleen P-PALS, Thy1.2+/I-Ad+ cell ratio was subject to major early elevation, followed by a rapid and permanent decline to levels below the controls. Two high peaks of Lyt1+/Lyt2+ ratio were found in P-PALS, on day 10 and 16. In the C-PALS, a marked decline in Thy1.2+/I-Ad+ ratio was observed throughout the experiment. As determined by Vv, there was a marked early enlargement of P-PALS reaching the peak on day 4, and followed by a steady reduction reaching the control values on day 10. In peripheral blood, there was an initial increase of T-cells, leading to elevated Thy1.2+/I-Ad+ ratio and a subsequent elevation of Lyt1+/Lyt2+ ratio on day 8.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0232-1513
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
75-82
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:3096774-Animals,
pubmed-meshheading:3096774-Antibodies, Neoplasm,
pubmed-meshheading:3096774-Cytotoxicity, Immunologic,
pubmed-meshheading:3096774-Female,
pubmed-meshheading:3096774-Lymphocytes,
pubmed-meshheading:3096774-Mast-Cell Sarcoma,
pubmed-meshheading:3096774-Mice,
pubmed-meshheading:3096774-Mice, Inbred DBA,
pubmed-meshheading:3096774-Neoplasm Transplantation,
pubmed-meshheading:3096774-Spleen,
pubmed-meshheading:3096774-Thymus Gland,
pubmed-meshheading:3096774-Transplantation, Isogeneic
|
pubmed:year |
1986
|
pubmed:articleTitle |
Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. II. Morphometric assessment of immunoreactivity in the thymus and spleen related to lymphocyte subsets in peripheral blood.
|
pubmed:publicationType |
Journal Article
|